Brief: BrightPath Biotherapeutics says exercise of options
Jan 11 (Reuters) - BrightPath Biotherapeutics Co Ltd
4594.T :
* Says 6,500 units of its 12th series options were exercised
to
650,000 shares of its common stock from Jan. 10 to Jan. 11
Source text in Japanese: https://goo.gl/vgWBcX
Further company coverage: 4594.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724;
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))